IDH3A and metastatic prostate carcinoma: TCL was reported to be inversely correlated with prognosis in isocitrate dehydrogenase (IDH)‐mutant astrocytoma,30 whereas the total CNV burden in metastatic prostate cancer was significantly higher than that in nonmetastatic prostate cancer.31